180 Life Sciences Corp.
ATNF
$3.00
$0.8740.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14,732.20% | -121.48% | -248.26% | 91.85% | 100.32% |
| Total Depreciation and Amortization | -- | -- | -113.66% | -57.49% | -16.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 176.80% | 144.44% | 441.79% | -100.28% | -125.13% |
| Change in Net Operating Assets | -40.47% | 519.64% | 134.56% | -43.48% | 39,447.62% |
| Cash from Operations | -255.54% | 17.39% | 55.99% | 87.40% | 123.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -32.13% | 98.75% | -20.35% | -84.82% | -2.79% |
| Issuance of Common Stock | -- | -- | 546.22% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.13% | 98.75% | 243.44% | -119.46% | -110.76% |
| Foreign Exchange rate Adjustments | -413.75% | -80.00% | 5,977.55% | -1,321.47% | -52.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -420.26% | 33.79% | 739.32% | -245.50% | 173.76% |